By Business/Source
Currency:JPY
2025/FY
Stock NameRevenueRatio
Pharmaceutical business104M100.00%
By Country/Region
Currency:JPY
2025/FY
Stock NameRevenueRatio
Japan90M86.54%
United States14M13.46%
